
Opinion|Videos|November 8, 2024
Unmet Needs in Generalized Myasthenia Gravis
Key Takeaways
- Current MG treatments often have limited efficacy and significant side effects, necessitating more effective and targeted therapies.
- Early and accurate diagnosis is crucial, highlighting the need for better diagnostic tools in MG management.
Panelists discuss how certain aspects of myasthenia gravis management remain challenging, identifying ongoing unmet needs in diagnosis, treatment, and patient care.
Advertisement
Video content above is prompted by the following:
- What continue to be unmet needs in myasthenia gravis?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
New 3-Year EMBARK Data Highlights Continued Therapeutic Effect of Gene Therapy Elevidys in Duchenne
2
Priority Review Granted for Weekly Subcutaneous Lecanemab Dosing in Early Alzheimer Disease
3
Ocugen’s Stargardt Gene Therapy OCU410ST Provides +6-Letter Gain in BCVA-Evaluable Patients in Phase 1 Trial
4
FDA Lifts Clinical Hold on Intellia’s Trial for Gene Editing Therapy Nex-Z in ATTRv-PN, Places Holds on REGENXBIO MPS Trials
5










